Abstract
The incidence of prostate cancer is still increasing mostly due to the introduction of PSA blood tests and the widespread use of ultrasound-guided prostate biopsy. This one has evolved from the standard sextant biopsy method to more accurate PBx schemes, with the addition of more biopsies to areas not sampled by standard sextant schemes, configuring the concepts of extended and saturation biopsy. Nowadays, a random biopsy still represents the most important diagnostic tool to detect and characterize prostate cancer, leading to both new therapeutic and follow-up perspectives.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Scattoni V, Zlotta S, Montironi R, Schulman C, Rigatti P, Montorsi F (2007) Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol 52:1309–1322
Scattoni V, Roscigno M, Raber M, Dehò F, Maga T, Zanoni M, Riva M, Sangalli M, Nava L, Mazzoccoli B, Freschi M, Guazzoni G, Rigatti P, Montorsi F (2008) Initial extended transrectal prostate biopsy – are more prostate cancers detected with 18 cores than with 12 cores? J Urol 179(4):1327–1331
Eichler K, Hempel S, Wilby J et al (2006) Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 175:1605–1612
Li YH, Elshafei A, Li J, Gong M, Susan L, Fareed K, Jones JS (2013) Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen <10 ng/ml. Eur Urol 65(6):1178–1183
Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA Jr (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level <=4.0 ng per milliliter. N Engl J Med 350(22):2239–2246
Gilbert SM, Cavallo CB, Kahane H, Lowe FC (2005) Evidence suggesting PSA cutpoint of 2.5 ng/mL for prompting prostate biopsy: review of 36,316 biopsies. Urology 65(3):549–553
Stephan C, Stroebel G, Heinau M, Lenz A, Roemer A, Lein M, Schnorr D, Loening SA, Jung K (2005) The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of <4 ng/mL. Cancer 104(5):993–1003
Perrin P (2006) PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence. Eur Urol 49(3):418–419
Lazzeri M, Haese A, de la Taille A, Palou Redorta J, McNicholas T, Lughezzani G, Scattoni V, Bini V, Freschi M, Sussman A, Ghaleh B, Le Corvoisier P, Alberola Bou J, Esquena Fernández S, Graefen M, Guazzoni G (2013) Serum isoform [−2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2–10 ng/ml: a multicentric European study. Eur Urol 63(6):986–994
Ukimura O, Coleman JA, de la Taille A, Emberton M, Epstein JI, Freedland SJ, Giannarini G, Kibel AS, Montironi R, Ploussard G, Roobol MJ, Scattoni V, Jones JS (2013) Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol 63(2):214–230
Maccagnano C, Scattoni V, Roscigno M, Raber M, Angiolilli D, Montorsi F, Rigatti P (2011) Anaesthesia in transrectal prostate biopsy: which is the most effective technique? Urol Int 87(1):1–13
Ploussard G, Nicolaiew N, Marchand C, Terry S, Vacherot F, Vordos D, Allory Y, Abbou CC, Salomon L, de la Taille A (2014) Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy. Eur Urol 65(1):154–161
Toi A, Neill M, Gina A et al (2007) The continuing importance of transrectal ultrasound identification of prostatic lesions. J Urol 177:516–520
Pummer K, Rieken M, Augustin H, Gutschi T, Shariat SF (2014) Innovations in diagnostic imaging of localized prostate cancer. World J Urol 32(4):881–890
Moore CM, Robertson NL, Arsanious N, Middleton T, Villers A, Klotz L, Taneja SS, Emberton M (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63(1):125–140
Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA (2013) Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 64(5):713–719
Scattoni V, Raber M, Abdollah F et al (2010) Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy. Eur Urol 57(1):1–8
Jiang X, Zhu S, Feng G, Zhang Z, Li C, Li H, Wang C, Xu Y (2013) Is an initial saturation prostate biopsy scheme better than an extended scheme for detection of prostate cancer? A systematic review and meta-analysis. Eur Urol 63(6):1031–1039
Zaytoun OM, Moussa AS, Gao T, Fareed K, Jones JS (2011) Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. J Urol 186(3):850–854
Scattoni V, Raber M, Capitanio U, Abdollah F, Roscigno M, Angiolilli D, Maccagnano C, Gallina A, Saccà A, Freschi M, Doglioni C, Rigatti P, Montorsi F (2011) The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme. Eur Urol 60(4):834–841
Scattoni V, Maccagnano C, Capitanio U, Gallina A, Briganti A, Montorsi F (2014) Random biopsy: when, how many and where to take the cores? World J Urol 32(4):859–869
Delongchamps NB, de la Roza G, Jones R, Jumbelic M, Haas GP (2009) Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer. BJU Int 103(1):49–54
Djavan B, Ravery V, Zlotta A et al (2001) Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 166:1679–1683
Campos-Fernandes JL, Bastien L, Nicolaiew N et al (2009) Prostate cancer detection rate in patients with repeat extended 21-sample needle biopsy. Eur Urol 55:600–609
Tan N, Lane B, Li J et al (2008) Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade. J Urol 180:1325–1329
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Scattoni, V., Maccagnano, C. (2017). Interventional Ultrasound: Prostatic Biopsy with Special Techniques (Saturation, Template). In: Martino, P., Galosi, A. (eds) Atlas of Ultrasonography in Urology, Andrology, and Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-319-40782-1_28
Download citation
DOI: https://doi.org/10.1007/978-3-319-40782-1_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40780-7
Online ISBN: 978-3-319-40782-1
eBook Packages: MedicineMedicine (R0)